WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric BjerkholtCHIEF FINANCIAL OFFICER2024-03-272,000$24.80
$49.60kBuy
Peter RadovichPRESIDENT AND COO2024-03-254,303$25.80
$111.02kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2024-03-182,000$25.80
$51.60kBuy
Pamela VigCHIEF SCIENTIFIC OFFICER2024-02-021,214$26.19
$31.80kSell
Jolanda HoweSVP GLOBAL CONTROLLER2024-02-02735$26.19
$19.25kSell
Lara LongpreCHIEF DEVELOPMENT OFFICER2024-02-02847$26.19
$22.18kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2024-02-026,013$26.19
$157.49kSell
Peter RadovichPRESIDENT AND COO2024-02-021,790$26.19
$46.88kSell
Lara LongpreCHIEF DEVELOPMENT OFFICER2024-01-081,019$28.04
$28.57kSell
Peter RadovichCHIEF OPERATING OFFICER2024-01-081,408$28.04
$39.47kSell

1 of 5

MIRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP13.82%6,495,392$158.62MInstitution
Bvf Inc9.30%4,370,024$106.72MInstitution
David M. Mott8.91%4,186,243$102.23MInsider
Joshua Makower8.91%4,186,243$102.23MInsider
Peter W. Sonsini8.91%4,186,243$102.23MInsider
Peter J. Barris8.91%4,186,243$102.23MInsider
Patrick J. Heron7.93%3,728,875$91.06MInsider
Frazier Life Sciences Ix LP7.59%3,566,912$87.10MInsider
James E. Flynn6.90%3,244,434$79.23MInsider
Eventide Asset Management LLC5.67%2,663,649$65.05MInstitution

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM48.94%51.06%Net BuyingNet Selling
MNKD30.01%69.99%Net BuyingNet Buying
TARS66.40%33.60%Net SellingNet Selling
AUTL43.49%0.00%
AKRO66.82%33.18%Net BuyingNet Buying
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 106.43% institutional shareholders, 111.06% Mirum Pharmaceuticals insiders, and 0.00% retail investors. David M. Mott is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 8.91% of the company. David M. Mott's Mirum Pharmaceuticals shares are currently valued at $100.55M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.